Characterization of β2-adrenergic receptor dephosphorylation: comparison with the rate of resensitization

Molecular Pharmacology

Volumn 71, Issue 1, 2007, Pages 47-60

  Tran, Tuan M ^a   Friedman, Jacqueline ^a   Baameur, Faiza ^a   Knoll, Brian J ^c   Moore, Robert H ^b   Clark, Richard B ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; G PROTEIN COUPLED RECEPTOR KINASE; ISOPRENALINE; PHOSPHOSERINE; RHODOPSIN KINASE;

ARTICLE; DEPHOSPHORYLATION; DRUG EFFECT; FRACTIONATION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; KINETICS; PRIORITY JOURNAL; CELL LINE; CELL MEMBRANE; ENZYMOLOGY; KIDNEY; METABOLISM;

ADENYLATE CYCLASE; CELL LINE; CELL MEMBRANE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; ISOPROTERENOL; KIDNEY; KINETICS; PHOSPHOSERINE; RECEPTORS, ADRENERGIC, BETA-2; RHODOPSIN KINASE;

EID: 33845868504     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.028456     Document Type: Article

References (43)

1. Benovic JL, Kuhn H, Weyand I, Codina J, Caron MG, and Lefkowitz RJ (1987) Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 84:8879-8882.
2. Clark RB, Friedman J, Prashad N, and Ruoho AE (1985) Epinephrine-induced sequestration of the beta-adrenergic receptor in cultured S49 WT and cyc- lymphoma cells. J Cyclic Nucleotide Protein Phosphor Res 10:97-119.
3. Clark RB, Knoll BJ, and Barber R (1999) Partial agonists and G protein-coupled receptor desensitization. Trends Pharmacol Sci 20:279-286.
4. Contreras ML, Wolfe BB, and Molinoff PB (1986) Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. J Pharmacol Exp Ther 239:136-143.
5. Fan GH, Yang W, Sai J, and Richmond A (2001) Phosphorylation-independent association of CXCR2 with the protein phosphatase 2A core enzyme. J Biol Chem 276:16960-16968.
6. Gupta RC, Neumann J, Watanabe AM, and Sabbah HN (2002) Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium. Biochem Pharmacol 63:1069-1076.
7. Gurevich VV and Gurevich EV (2004) The molecular acrobatics of arrestin activation. Trends Pharmacol Sci 25:105-111.
8. Huang HB, Horiuchi A, Watanabe T, Shih SR, Tsay HJ, Li HC, Greengard P, and Nairn AC (1999) Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2. J Biol Chem 274:7870-7878.
9. Iyer V, Tran TM, Foster E, Dai W, Clark RB, and Knoll BJ (2006) Differential phosphorylation and dephosphorylation of beta(2)-adrenoceptor sites Ser262 and Ser355,356. Br J Pharmacol 147:249-259.
10. January B, Seibold A, Allal C, Whaley BS, Knoll BJ, Moore RH, Dickey BF, Barber R, and Clark RB (1998) Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol 123:701-711.
11. January B, Seibold A, Whaley B, Hipkin RW, Lin D, Schonbrunn A, Barber R, and Clark RB (1997) β2-Adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem 272:23871-23879.
12. Kelly E (2006) G-protein-coupled receptor dephosphorylation at the cell surface. Br J Pharmacology 147:235-236.
13. Krasel C, Bunemann M, Lorenz K, and Lohse MJ (2005) Beta-arrestin binding to the β2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem 280:9528-9535.
14. Krueger KM, Daaka Y, Pitcher JA, and Lefkowitz RJ (1997) The role of sequestration in G protein-coupled receptor resensitization. Regulation of β2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem 272:5-8.
15. Krupnick JG and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
16. Liang W, Curran PK, Hoang Q, Moreland RT, and Fishman PH (2004) Differences in endosomal targeting of human (beta)1- and (beta)2-adrenergic receptors after clathrin-mediated endocytosis. J Cell Sci 117:723-734.
17. Liang W and Fishman PH (2004) Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation. J Biol Chem 279:46882-46889.
18. Lohse MJ, Andexinger S, Pitcher J, Trukawinski S, Codina J, Faure JP, Caron MG, and Lefkowitz RJ (1992) Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of β-arrestin and arrestin in the β2-adrenergic receptor and rhodopsin systems. J Biol Chem 267:8558-8564.
19. Lohse MJ, Benovic JL, Caron MG, and Lefkowitz RJ (1990a) Multiple pathways of rapid β2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem 265:3202-3211.
20. Lohse MJ, Benovic JL, Codina J, Caron MG, and Lefkowitz RJ (1990b) β-Arrestin: a protein that regulates beta-adrenergic receptor function. Science (Wash DC) 248:1547-1550.
21. Lohse MJ, Lefkowitz RJ, Caron MG, and Benovic JL (1989) Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors. Proc Natl Acad Sci USA 86:3011-3015.
22. Malbon CC, Tao J, and Wang HY (2004) AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes. Biochem J 379:1-9.
23. McLean AJ and Milligan G (2000) Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. Br J Pharmacol 130:1825-1832.
24. Morrison KJ, Moore RH, Carsrud ND, Trial J, Millman EE, Tuvim M, Clark RB, Barber R, Dickey BF, and Knoll BJ (1996) Repetitive endocytosis and recycling of the β2-adrenergic receptor during agonist-induced steady state redistribution. Mol Pharmacol 50:692-699.
25. Pippig S, Andexinger S, and Lohse MJ (1995) Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 47:666-676.
26. Pitcher JA, Payne ES, Csortos C, DePaoli-Roach AA, and Lefkowitz RJ (1995) The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. Proc Natl Acad Sci USA 92:8343-8347.
27. 2-adrenergic receptors with mutations of the proposed G protein-coupled receptor kinase phosphorylation sites. J Biol Chem 273:7637-7642.
28. 2-adrenergic receptor by the GRK pathway. Mol Pharmacol 58:1162-1173.
29. Shenoy SK and Lefkowitz RJ (2005) Receptor-specific ubiquitination of β-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem 280:15315-15324.
30. 2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem 274:1588-1595.
31. Sibley DR, Strasser RH, Benovic JL, Daniel K, and Lefkowitz RJ (1986) Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proc Natl Acad Sci USA 83:9408-9412.
32. Sike S and Shenolikar S (2005) Protein phosphatase inhibitor-1, an amplifier of cAMP signals. Cellscience Rev 2.
33. Sohlemann P, Hekman M, Puzicha M, Buchen C, and Lohse MJ (1995) Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein- coupled receptors. Eur J Biochem 232:464-472.
34. Stickle D and Barber R (1989) Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase. Mol Pharmacol 36:437-445.
35. Stickle D and Barber R (1991) Estimation of the kinetic constants for binding of epinephrine to beta-adrenergic receptors of the S49 cell. Biochem Pharmacol 42:1069-1077.
36. Tran TM, Friedman J, Qunaibi E, Baameur F, Moore RH, and Clark RB (2004) Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the β2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol 65:196-206.
37. Trester-Zedlitz M, Burlingame A, Kobilka B, and von Zastrow M (2005) Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. Biochemistry 44:6133-6143.
38. 2-adrenergic receptor internalization, desensitization, and β-arrestin translocation. J Biol Chem 281:7684-7692.
39. Whaley BS, Yuan N, Birnbaumer L, Clark RB, and Barber R (1994) Differential expression of the β-adrenergic receptor modifies agonist stimulation of adenylylcyclase: a quantitative evaluation. Mol Pharmacol 45:481-489.
40. 2-adrenergic receptor and rhodopsin by latent phosphatase 2. J Biol Chem 263:8856-8858.
41. Yu SS, Lefkowitz RJ, and Hausdorff WP (1993) β-Adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J Biol Chem 268:337-341.
42. Zhang J, Barak LS, Anborgh PH, Laporte SA, Caron MG, and Ferguson SS (1999) Cellular trafficking of G protein-coupled receptor/β-arrestin endocytic complexes. J Biol Chem 274:10999-11006.
43. Zhang J, Barak LS, Winkler KE, Caron MG, and Ferguson SS (1997) A central role for β-arrestins and clathrin-coated vesicle-mediated endocytosis in β2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem 272:27005-27014.